Our use of a kidney cancer cell line for these studies was prompted by the facts that (i) kidney cancer is exquisitely chemotherapy-resistant such that 5-year survival for the metastatic form of the disease is less than 10% [36], and (ii) decreased PTEN expression is frequently seen in this disease[8,9]. Here, PTEN is linked to kidney cancer.